Which of the following statements is true regarding kidney tumors -a) Mutated VHL gene is associated with clear cell carcinomab) Extreme hyperdiploidy occursc) Extreme hypodiploidy occursd) Renal papillary carcinoma has defect in chromosome 8e) Oncocytoma has defect in chromosome 11

**Core Concept**
The question tests knowledge of genetic alterations associated with specific types of kidney tumors. Clear cell carcinoma, a common type of renal cell carcinoma, is known to be associated with mutations in the von Hippel-Lindau (VHL) gene.

**Why the Correct Answer is Right**
The VHL gene acts as a tumor suppressor, regulating the degradation of hypoxia-inducible factor-alpha (HIF-α), a transcription factor that promotes angiogenesis and cell proliferation. Mutations in the VHL gene lead to the accumulation of HIF-α, resulting in the activation of genes involved in angiogenesis and cell proliferation, ultimately contributing to the development of clear cell carcinoma. This is a classic example of a tumor suppressor gene mutation leading to cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** Extreme hyperdiploidy is a characteristic of certain hematological malignancies, such as Burkitt lymphoma, but it is not typically associated with kidney tumors.

**Option B:** Extreme hypodiploidy is more commonly associated with certain types of leukemia and lymphoma, rather than kidney tumors.

**Option D:** Renal papillary carcinoma is associated with mutations in the MET gene, which encodes the hepatocyte growth factor receptor, not defects in chromosome 8.

**Option E:** Oncocytomas are benign kidney tumors that are typically associated with trisomy 7 and trisomy 17, not defects in chromosome 11.

**Clinical Pearl / High-Yield Fact**
The VHL gene is a tumor suppressor gene that is involved in the regulation of angiogenesis and cell proliferation. Mutations in this gene are associated with clear cell carcinoma, the most common type of renal cell carcinoma.

**Correct Answer: a) Mutated VHL gene is associated with clear cell carcinoma.**